Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Third-Party Risk Management Focus Groups Third-Party Risk Management Focus Groups: New Best Practices for Mitigating Unique Corruption Risks of Third-Party Business Dealings in the Pharmaceutical, Biotech and Medical Device Industries

Presentation and Speech May 7, 2025

ACI's 20th Annual FCPA & Anti-Corruption for the Life Sciences Industry

Jennifer was a panelist at the FCPA Anti-Corruption for the Life Sciences Industry Conference. Her session discussed new best practices for mitigating unique corruption risks of third-party business dealings in the pharmaceutical, biotech, and medical device industries.

Share links:

Share links:

Related Professionals

Related News & Insights